US States Restrict Abortion Access
Analysis based on 12 articles · First reported Jun 30, 2026 · Last updated Jul 02, 2026
The new laws in United States — Iowa, United States — Mississippi, and United States — Tennessee are expected to negatively impact pharmaceutical companies producing mifepristone and misoprostol due to restricted access and distribution. Healthcare providers and insurance companies in these states may face increased legal risks and potential malpractice insurance rate increases, as seen in the context of United States — Hawaii's shield laws.
Several new laws have taken effect in United States — Iowa, United States — Mississippi, and United States — Tennessee that restrict access to abortion medications like mifepristone and misoprostol, and limit minors' access to sexual and reproductive healthcare, including the HPV vaccine. United States — Mississippi's law criminalizes the distribution of abortion drugs, punishable by up to 10 years in prison. United States — Iowa now requires in-person dispensing of these medications and prohibits minors from consenting to STD vaccinations. United States — Tennessee has imposed new restrictions allowing the state attorney general to levy significant fines for violations of in-person dispensing requirements. These legislative changes are occurring amidst an ongoing federal lawsuit concerning the United States — Food and Drug Administration's rules on telehealth dispensing of mifepristone, which will have nationwide implications. In contrast, United States — Hawaii has strengthened its shield laws to protect abortion access and healthcare providers.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard